Genetic Mutation BRAFV600E Linked To Melanoma Progression
Thursday, September 11, 2014 - 17:00
in Health & Medicine
The genetic mutation BRAFV600E secretes a protein that promotes the growth of melanoma tumor cells and modify the network of normal cells around the tumor to support the disease's progression, according to a new paper. Targeting this mutation with Vemurafenib reduces this interaction, and suggests possible new treatment options for melanoma therapy. BRAFV600E is common present in metastatic melanoma. read more